0001493152-22-025319.txt : 20220908
0001493152-22-025319.hdr.sgml : 20220908
20220908090030
ACCESSION NUMBER: 0001493152-22-025319
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220906
FILED AS OF DATE: 20220908
DATE AS OF CHANGE: 20220908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meckler Jeffrey A
CENTRAL INDEX KEY: 0001506916
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40652
FILM NUMBER: 221232668
MAIL ADDRESS:
STREET 1: 740 BROADWAY
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001857044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863158720
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (646) 427-2727
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Intec Parent Inc.
DATE OF NAME CHANGE: 20210414
4
1
ownership.xml
X0306
4
2022-09-06
0
0001857044
Indaptus Therapeutics, Inc.
INDP
0001506916
Meckler Jeffrey A
C/O INDAPTUS THERAPEUTICS, INC.
3 COLUMBUS CIRCLE, 15TH FLOOR
NEW YORK
NY
10019
1
1
0
0
CEO and Director
Common stock
2022-09-06
2022-09-06
4
P
0
1060
2.44
A
46434
D
Common stock
2022-09-07
2022-09-07
4
P
0
8632
2.57
A
55066
D
/s/ Jeffrey Meckler
2022-09-08